Fibrates inhibit the apoptosis of Batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential

In Vitro Cellular and Developmental Biology - Animal

Volumn 52, Issue 3, 2016, Pages 349-355

  Hong, Minho ^a   Song, Ki Duk ^b   Lee, Hak Kyo ^b   Yi, SunShin ^c   Lee, Yong Seok ^c   Heo, Tae Hwe ^d   Jun, Hyun Sik ^e   Kim, Sung Jo ^a  

^a Hoseo University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Soonchunhyang University   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Korea University   (South Korea)

Author keywords

Autophagy; Batten disease; Lymphoblast; Mitochondria; PPAR

Indexed keywords

BEZAFIBRATE; CHAPERONE; CLN3 PROTEIN, HUMAN; FENOFIBRATE; GEMFIBROZIL; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

AGONISTS; APOPTOSIS; AUTOPHAGY; CELL CULTURE; DRUG EFFECTS; GENETICS; HUMAN; LYMPHOCYTE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEURONAL CEROID LIPOFUSCINOSIS; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; AUTOPHAGY; BEZAFIBRATE; CELLS, CULTURED; FENOFIBRATE; GEMFIBROZIL; HUMANS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PPAR ALPHA;

EID: 84949555128     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-015-9979-7     Document Type: Article

References (36)

1. Barbiero JK, Santiago R, Tonin FS, Boschen S, da Silva LM, Werner MF, da Cunha C, Lima MM, Vital MA (2014) PPAR-alpha agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 53:35–44
2. Beltowski J, Wojcicka G, Mydlarczyk M, Jamroz A (2002) The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity. J Physiol Pharmacol 53:463–475
3. Benedict JW, Sommers CA, Pearce DA (2007) Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease. J Neurosci Res 85:2882–2891
4. Bennett MJ, Rakheja D (2013) The neuronal ceroid-lipofuscinoses. Dev Disabil Res Rev 17:254–259
5. Bible E, Gupta P, Hofmann SL, Cooper JD (2004) Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 16:346–359
6. Cao Y, Espinola JA, Fossale E, Massey AC, Cuervo AM, MacDonald ME, Cotman SL (2006) Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J Biol Chem 281:20483–20493
7. Cho YR, Lim JH, Kim MY, Kim TW, Hong BY, Kim YS, Chang YS, Kim HW, Park CW (2014) Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice. PLoS One 9:e83204
8. Combs CK, Bates P, Karlo JC, Landreth GE (2001) Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem Int 39:449–457
9. De Silva DS, Wilson RM, Hutchinson C, Ip PC, Garcia AG, Lancel S, Ito M, Pimentel DR, Sam F (2009) Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms. Am J Physiol Heart Circ Physiol 296:H1983–1993
10. Deplanque D, Gele P, Petrault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart JC, Cecchelli R, Staels B, Duriez P, Bordet R (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 23:6264–6271
11. Elijah IE, Borsheim E, Maybauer DM, Finnerty CC, Herndon DN, Maybauer MO (2012) Role of the PPAR-alpha agonist fenofibrate in severe pediatric burn. Burns 38:481–486
12. Kang S, Seo JH, Heo TH, Kim SJ (2013) Batten disease is linked to altered expression of mitochondria-related metabolic molecules. Neurochem Int 62:931–935
13. Kang S, Heo TH, Kim SJ (2014) Altered levels of alpha-synuclein and sphingolipids in Batten disease lymphoblast cells. Gene 539:181–185
14. Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, Raza SS, Khan A, Javed H, Vaibhav K, Islam F (2010) Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res 1328:139–151
15. Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802:396–405
16. Kim SJ, Zhang Z, Hitomi E, Lee YC, Mukherjee AB (2006) Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL. Hum Mol Genet 15:1826–1834
17. Kim SJ, Zhang Z, Sarkar C, Tsai PC, Lee YC, Dye L, Mukherjee AB (2008) Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to neuropathology in humans and mice. J Clin Invest 118:3075–3086
18. Kim SJ, Zhang Z, Saha A, Sarkar C, Zhao Z, Xu Y, Mukherjee AB (2010) Omega-3 and omega-6 fatty acids suppress ER- and oxidative stress in cultured neurons and neuronal progenitor cells from mice lacking PPT1. Neurosci Lett 479:292–296
19. Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, Saftig P, Uchiyama Y (2005) Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol 167:1713–1728
20. Lalloyer F, Staels B (2010) Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 30:894–899
21. Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A (2012) Autophagy in lysosomal storage disorders. Autophagy 8:719–730
22. Olukman M, Sezer ED, Ulker S, Sozmen EY, Cinar GM (2010) Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats. Exp Diabetes Res 2010:828531
23. Osorio NS, Carvalho A, Almeida AJ, Padilla-Lopez S, Leao C, Laranjinha J, Ludovico P, Pearce DA, Rodrigues F (2007) Nitric oxide signaling is disrupted in the yeast model for Batten disease. Mol Biol Cell 18:2755–2767
24. Papi A, Guarnieri T, Storci G, Santini D, Ceccarelli C, Taffurelli M, De Carolis S, Avenia N, Sanguinetti A, Sidoni A, Orlandi M, Bonafe M (2012) Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ 19:1208–1219
25. Persaud-Sawin DA, Boustany RM (2005) Cell death pathways in juvenile Batten disease. Apoptosis 10:973–985
26. Persaud-Sawin DA, VanDongen A, Boustany RM (2002) Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis. Hum Mol Genet 11:2129–2142
27. Phillips SN, Benedict JW, Weimer JM, Pearce DA (2005) CLN3, the protein associated with batten disease: structure, function and localization. J Neurosci Res 79:573–583
28. Sahebkar A, Simental-Mendia LE, Watts GF, Golledge J (2015) Impact of fibrate therapy on plasma plasminogen activator inhibitor-1: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis 240:284–296
29. Seehafer SS, Pearce DA (2009) Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease. Biochem Biophys Res Commun 382:247–251
30. Tuxworth RI, Chen H, Vivancos V, Carvajal N, Huang X, Tear G (2011) The Batten disease gene CLN3 is required for the response to oxidative stress. Hum Mol Genet 20:2037–2047
31. Valentine JS, Doucette PA, Zittin Potter S (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563–593
32. Wang SH, Shih YL, Ko WC, Wei YH, Shih CM (2008) Cadmium-induced autophagy and apoptosis are mediated by a calcium signaling pathway. Cell Mol Life Sci 65:3640–3652
33. Wei H, Kim SJ, Zhang Z, Tsai PC, Wisniewski KE, Mukherjee AB (2008) ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum Mol Genet 17:469–477
34. Wierzbicki AS, Viljoen A (2014) Fibrates and niacin: is there a place for them in clinical practice? Expert Opin Pharmacother 15:2673–2680
35. Yoon DH, Kwon OY, Mang JY, Jung MJ, Kim do Y, Park YK, Heo TH, Kim SJ (2011) Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells. Biochem Biophys Res Commun 414:49–52
36. Zimetbaum P, Frishman WH, Kahn S (1991) Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol 31:25–37